Atropos Health furthers commitment to Oncology with addition of Ontada data

Read the release
Learn more
Logo
  • Solutions
        • Health Systems
          • Pharmacy
          • Research Informatics
          • Value Based Care / Quality
          • GME
        • Life Sciences
          • Brand Analytics
          • Precision Medicine AI/ML
          • HEOR, Medical Affairs & RWE
          • Research & Development
  • Technology
        • Platform
          • GENEVA OS®
        • Evidence Generation Tools
          • ChatRWD®
          • Green Button™
          • Alexandria®
          • Forge®
        • Data
          • Atropos Evidence® Network
          • Data Quality Scoring
  • About
    • About Us
    • Careers
  • Resources
    • Resource Center
    • Publications
    • Customer Stories
    • News & Media
    • Press Releases
  • Contact Us
  • Login
Inside the Clinical Decision Support Market: The Race to Make AI Work at the Point of Care

Inside the Clinical Decision Support Market: The Race to Make AI Work at the Point of Care

by Julia Rudo | Sep 12, 2025 | News and Media

A recent MedCity News article discussing the competitive clinical decision support market positions Atropos Health as a key player with a differentiated approach. Amid a landscape of companies focusing on synthesis of existing literature, Atropos Health is unique in...
Answered with Evidence (with updates) – a framework for evaluating whether LLM responses to biomedical questions are founded in evidence.

Answered with Evidence (with updates) – a framework for evaluating whether LLM responses to biomedical questions are founded in evidence.

by Julia Rudo | Sep 5, 2025 | Publications

A paper titled, “Introducing Answered with Evidence – A framework for evaluating whether large language model (LLM) responses to biomedical questions are founded in evidence,” was published in medrxiv by authors affiliated with Atropos Health as an update to a prior...
Atropos Health, Novartis partner for earlier detection of rare blood disorder

Atropos Health, Novartis partner for earlier detection of rare blood disorder

by Julia Rudo | Aug 25, 2025 | News and Media

“Atropos Health announced a partnership with pharmaceutical giant Novartis, {beginning with an AI model} to help identify individuals with the rare disease paroxysmal nocturnal hemoglobinuria (PNH) who have not yet been diagnosed. PNH is a rare blood disorder of the...
Atropos Health Enters Into Strategic Collaboration to Reduce Time to Rare Disease Diagnosis with Artificial Intelligence (AI) Algorithm

Atropos Health Enters Into Strategic Collaboration to Reduce Time to Rare Disease Diagnosis with Artificial Intelligence (AI) Algorithm

by Julia Rudo | Aug 18, 2025 | Press Release

Real-World Evidence and Longitudinal Patient Records-Driven Algorithm Delivers Actionable, AI-Powered Insights at the Point of Care Atropos Health and Novartis are collaborating to improve the diagnosis of Paroxysmal Nocturnal Hemoglobinuria (PNH), a rare blood...
Atropos Health study ranks AI models by how well they summarize medical research

Atropos Health study ranks AI models by how well they summarize medical research

by Julia Rudo | Aug 13, 2025 | News and Media

“With AI wearing ever-more hats in all kinds of workplaces, researchers are scrambling to devise tests that grade how well the technology actually performs in its myriad roles. In healthcare alone, several new benchmarks aim to gauge AI’s prowess in medical settings....
« Older Entries
DiviWP Logo
  • Follow
  • Follow

Solutions

Health Systems

Pharmacy

Research Informatics

Value Based Care / Quality

GME

Life Sciences

Brand Analytics

Precision Medicine AI/ML

HEOR, Medical Affairs & RWE

Research & Development

Technology

Platform

GENEVA OS®

Evidence Generation Tools

ChatRWD®

Green Button™

Alexandria®

Forge®

Data

Atropos Evidence™ Network

Data Quality Scoring

About

  • About Us
  • Careers

Resources

  • Resources Center
  • Publications
  • Customer Stories
  • News & Media
  • Press Releases

Copyright © 2025 Atropos Health. All Rights Reserved | Privacy Policy | Ethics Report | Terms of Service

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}